Cannabinoid Encyclopedia

Focused research review

How does THCV affect appetite and metabolism?

What evidence connects THCV with appetite-related or metabolic outcomes?

Updated July 2026 13 research sources Human and early research

The short answer

What is the bottom line?

Research has examined THCV and appetite and metabolism. This page brings together 7 human-study sources, 3 research reviews, and 3 lab, animal, or mechanism sources. The source set includes human research as well as earlier-stage studies. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about THCV and appetite and metabolism.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on THCV and appetite and metabolism covers Appetite and metabolic outcomes; those areas should not be combined into one claim. 1

  2. 2

    The source set includes human research as well as earlier-stage studies. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about THCV and appetite and metabolism

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

Appetite and metabolic outcomes

This part of the literature focuses on Appetite and metabolic outcomes. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

7 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

3 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

3 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on THCV and appetite and metabolism is not one kind of study. This source set includes 4 cell or laboratory studies, 4 clinical studies in people, 3 narrative or expert reviews, and 2 animal studies. 3

The recorded populations or models include people or patients (8 sources), animal models (2 sources), and cells or tissue models (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is appetite-related or metabolic outcomes (13 sources). Closely related outcome names can still describe different measurements. 5

The THCV and appetite and metabolism source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).

On this page, this source examines THCV and appetite and metabolic outcomes. 1

Study type
narrative or expert review
Population or model
animal models
Outcome focus
appetite-related or metabolic outcomes
Evidence stage
evidence still limited

clinical study in people

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.

On this page, this source examines THCV and appetite and metabolic outcomes. 2

Study type
clinical study in people
Population or model
people or patients
Outcome focus
appetite-related or metabolic outcomes
Evidence stage
mechanism-focused research

narrative or expert review

The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management.

On this page, this source examines THCV and appetite and metabolic outcomes. 3

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
appetite-related or metabolic outcomes
Evidence stage
evidence still limited

clinical study in people

Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes.

On this page, this source examines THCV and appetite and metabolic outcomes. 4

Study type
clinical study in people
Population or model
people or patients
Outcome focus
appetite-related or metabolic outcomes
Evidence stage
human research

clinical study in people

Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.

On this page, this source examines THCV and appetite and metabolic outcomes. 5

Study type
clinical study in people
Population or model
people or patients
Outcome focus
appetite-related or metabolic outcomes
Evidence stage
human research

Safety and limits

What should readers keep in mind?

Research on THCV and appetite and metabolism should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects THCV with appetite-related or metabolic outcomes?

Relevant research is collected here. The source set includes human research as well as earlier-stage studies. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant). narrative or expert review; evidence still limited PubMed 21740450 DOI 10.1111/j.1365-2710.2011.01284.x
  2. 2
    Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. clinical study in people; mechanism-focused research PubMed 27573936 DOI 10.2337/dc16-0650
  3. 3
    The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management. narrative or expert review; evidence still limited PubMed 40270953 DOI 10.3934/neuroscience.2025003
  4. 4
    Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. clinical study in people; human research PubMed 33526143 DOI 10.1186/s42238-020-0016-7
  5. 5
    Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. clinical study in people; human research PubMed 11599601 DOI 10.1093/jat/25.7.565
  6. 6
    Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips. clinical study in people; mechanism-focused research PubMed 39968488 DOI 10.26828/cannabis/2024/000206
  7. 7
    It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets. narrative or expert review; evidence still limited PubMed 32899626 DOI 10.3390/molecules25184036
  8. 8
    High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain. animal study; mechanism-focused research PubMed 32904155 DOI 10.7717/peerj.9811
  9. 9
    In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. animal study; mechanism-focused research PubMed 33230154 DOI 10.1038/s41598-020-77175-y
  10. 10
    Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages. cell or laboratory study; mechanism-focused research PubMed 37764262 DOI 10.3390/molecules28186487
  11. 11
    SKNY-1, a THCV Analog, Produces Weight Loss, Lipid Normalization and Attenuation of Reward-Associated Behaviors in an mc4r(G894C) Zebrafish Model of Obesity. cell or laboratory study; mechanism-focused research PubMed 42196303 DOI 10.3390/ijms27104321
  12. 12
    Tetrahydrocannabivarin (THCV) Protects Adipose-Derived Mesenchymal Stem Cells (ASC) against Endoplasmic Reticulum Stress Development and Reduces Inflammation during Adipogenesis. cell or laboratory study; mechanism-focused research PubMed 37108282 DOI 10.3390/ijms24087120
See all 13 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. clinical study in people; human research / 1 linked research note PubMed 33526143
  2. The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management. narrative or expert review; evidence still limited / 1 linked research note PubMed 40270953
  3. It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets. narrative or expert review; evidence still limited / 1 linked research note PubMed 32899626
  4. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. clinical study in people; mechanism-focused research / 1 linked research note PubMed 27573936
  5. CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant). narrative or expert review; evidence still limited / 1 linked research note PubMed 21740450
  6. SKNY-1, a THCV Analog, Produces Weight Loss, Lipid Normalization and Attenuation of Reward-Associated Behaviors in an mc4r(G894C) Zebrafish Model of Obesity. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 42196303
  7. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. animal study; mechanism-focused research / 1 linked research note PubMed 33230154
  8. Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips. clinical study in people; mechanism-focused research / 1 linked research note PubMed 39968488
  9. The Impact of Major and Minor Phytocannabinoids on the Maintenance and Function of INS-1 β-Cells Under High-Glucose and High-Lipid Conditions. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 40363798
  10. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. clinical study in people; human research / 1 linked research note PubMed 11599601
  11. Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 37764262
  12. Tetrahydrocannabivarin (THCV) Protects Adipose-Derived Mesenchymal Stem Cells (ASC) against Endoplasmic Reticulum Stress Development and Reduces Inflammation during Adipogenesis. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 37108282
  13. High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain. animal study; mechanism-focused research / 1 linked research note PubMed 32904155